After finishing at $42.12 in the prior trading day, Baxter International Inc. (NYSE: BAX) closed at $41.34, down -1.85%. In other words, the price has decreased by -$0.78 from its previous closing price. On the day, 3863334 shares were traded. BAX stock price reached its highest trading level at $41.63 during the session, while it also had its lowest trading level at $41.00.
Top 5 EV Tech Stocks to Buy for 2023
According a new report published by BloombergNEF on investment in the energy transition, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now.
Click Here to Download the FREE Report.
Our goal is to gain a better understanding of BAX by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 12.51 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 109.02. For the most recent quarter (mrq), Quick Ratio is recorded 1.10 and its Current Ratio is at 1.70. In the meantime, Its Debt-to-Equity ratio is 2.79 whereas as Long-Term Debt/Eq ratio is at 2.60.
Upgrades & Downgrades
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 20 when STROUCKEN ALBERT P L sold 3,930 shares for $37.52 per share. The transaction valued at 147,454 led to the insider holds 36,835 shares of the business.
Kunzler Jacqueline sold 3,813 shares of BAX for $154,426 on Feb 21. The SVP, Chief Quality Officer now owns 16,725 shares after completing the transaction at $40.50 per share. On Jan 17, another insider, Mason Jeanne K, who serves as the SVP, Human Resources of the company, sold 59,477 shares for $44.70 each. As a result, the insider received 2,658,622 and left with 126,231 shares of the company.
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BAX now has a Market Capitalization of 24.12B and an Enterprise Value of 39.33B. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.39 while its Price-to-Book (P/B) ratio in mrq is 3.55. Its current Enterprise Value per Revenue stands at 2.60 whereas that against EBITDA is -73.52.
Stock Price History:
Over the past 52 weeks, BAX has reached a high of $77.08, while it has fallen to a 52-week low of $37.35. The 50-Day Moving Average of the stock is 42.67, while the 200-Day Moving Average is calculated to be 49.11.
The stock has traded on average 5.86M shares per day over the past 3-months and 4.01M shares per day over the last 10 days, according to various share statistics. A total of 505.00M shares are outstanding, with a floating share count of 503.13M. Insiders hold about 0.24% of the company’s shares, while institutions hold 89.50% stake in the company. Shares short for BAX as of Apr 27, 2023 were 6.04M with a Short Ratio of 5.71M, compared to 9.32M on Mar 30, 2023. Therefore, it implies a Short% of Shares Outstanding of 1.19% and a Short% of Float of 1.33%.
Dividends & Splits
In the trailing 12 months, BAX’s forward annual dividend rate was 1.16, compared to 1.16 this year. Against a Trailing Annual Dividend Yield of 2.75%, it implies a Forward Annual Dividend Yield of 2.73%. The stock’s 5-year Average Dividend Yield is 1.33.
Its stock is currently analyzed by 14 different market analysts. On average, analysts expect EPS of $0.61 for the current quarter, with a high estimate of $0.66 and a low estimate of $0.6, while EPS last year was $0.87. The consensus estimate for the next quarter is $0.8, with high estimates of $0.88 and low estimates of $0.77.
Analysts are recommending an EPS of between $3.06 and $2.85 for the fiscal current year, implying an average EPS of $2.94. EPS for the following year is $3.33, with 16 analysts recommending between $3.54 and $3.15.
12 analysts predict $3.8B in revenue for the current quarter. It ranges from a high estimate of $3.82B to a low estimate of $3.76B. As of the current estimate, Baxter International Inc.’s year-ago sales were $3.75B, an estimated increase of 1.30% from the year-ago figure. For the next quarter, 12 analysts are estimating revenue of $3.88B, an increase of 2.80% over than the figure of $1.30% in the same quarter last year. There is a high estimate of $3.91B for the next quarter, whereas the lowest estimate is $3.83B.
A total of 16 analysts have provided revenue estimates for BAX’s current fiscal year. The highest revenue estimate was $15.44B, while the lowest revenue estimate was $15.26B, resulting in an average revenue estimate of $15.35B. In the same quarter a year ago, actual revenue was $15.11B, up 1.60% from the average estimate. Based on 16 analysts’ estimates, the company’s revenue will be $15.96B in the next fiscal year. The high estimate is $16.21B and the low estimate is $15.71B. The average revenue growth estimate for next year is up 4.00% from the average revenue estimate for this year.